Thermo Fisher Scientific Q3 2024 Adj. EPS $5.28 Beats $5.25 Estimate, Sales $10.598B Miss $10.638B Estimate
Portfolio Pulse from Benzinga Newsdesk
Thermo Fisher Scientific reported its Q3 2024 financial results, with adjusted EPS of $5.28 beating the estimate of $5.25, but sales of $10.598 billion missing the expected $10.638 billion.
October 23, 2024 | 10:01 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Thermo Fisher Scientific's Q3 2024 adjusted EPS of $5.28 surpassed expectations, but sales fell short at $10.598 billion compared to the $10.638 billion estimate.
The EPS beat suggests operational efficiency or cost management, which is positive. However, the sales miss indicates potential challenges in revenue generation, balancing the overall impact to neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100